SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001193125-20-298749
Filing Date
2020-11-20
Accepted
2020-11-20 08:32:59
Documents
2
Period of Report
2020-09-09
Items
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K AMENDMENT NO 1 d79037d8ka.htm 8-K/A 19860
2 EX-23.1 d79037dex231.htm EX-23.1 6774
  Complete submission text file 0001193125-20-298749.txt   27811
Mailing Address 19900 MACARTHUR BLVD. SUITE 550 IRVINE CA 92612
Business Address 19900 MACARTHUR BLVD. SUITE 550 IRVINE CA 92612 949-238-8090
Novus Therapeutics, Inc. (Filer) CIK: 0001404281 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-36620 | Film No.: 201330530
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences